Vidya Raman-Tangella - Mar 1, 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Mar 1, 2024
Transactions value $
-$66,759
Form type
4
Date filed
3/5/2024, 04:08 PM
Previous filing
Feb 2, 2024
Next filing
Mar 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +3.17K +21.5% 17.9K Mar 1, 2024 Direct F1
transaction TDOC Common Stock Options Exercise +9.3K +51.94% 27.2K Mar 1, 2024 Direct F2
transaction TDOC Common Stock Sale -$66.8K -4.6K -16.9% $14.52 22.6K Mar 4, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Performance Stock Units Award $0 +9.51K $0.00 9.51K Mar 1, 2024 Common Stock 9.51K Direct F4, F5, F6
transaction TDOC Performance Stock Units Options Exercise $0 -3.17K -33.33% $0.00 6.34K Mar 1, 2024 Common Stock 3.17K Direct F1, F7
transaction TDOC Restricted Stock Units Options Exercise $0 -9.3K -33.33% $0.00 18.6K Mar 1, 2024 Common Stock 9.3K Direct F2, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4 Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
F5 Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
F6 The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F7 On March 1, 2024, the reporting person earned 9,509 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F8 On March 3, 2023, the reporting person was granted 27,902 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.